spironolactone has been researched along with piperidines in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Germán, MJ; Ibáñez, V; Murcia Sánchez, E; Pérez-Cerdá, F | 1 |
| Aznar, S; Brandwein, C; Chourbaji, S; Gass, P; Halldin, C; Kirkegaard, L; Knudsen, GM; Krey, G; Marcussen, AB; Ridder, S; Thomsen, MS; Trajkovska, V | 1 |
| Badolo, L; Bundgaard, C; Garmer, M; Jensen, B | 1 |
| Bitencourt, RM; Pamplona, FA; Takahashi, RN | 1 |
| Achterberg, EJ; Trezza, V; Vanderschuren, LJ | 1 |
| Adler, GK; Alvarez de la Rosa, D; El Mogrhabi, S; Fallo, F; Feraco, A; Jaisser, F; Nguyen Dinh Cat, A; Quilliot, D; Rossignol, P; Sierra-Ramos, C; Touyz, RM; Urbanet, R; Venteclef, N | 1 |
| Agarwal, R; Georgianos, PI | 1 |
1 review(s) available for spironolactone and piperidines
| Article | Year |
|---|---|
Management of hypertension in advanced kidney disease.
Topics: Blood Pressure; Chlorthalidone; Humans; Hyperkalemia; Hypertension; Mineralocorticoid Receptor Antagonists; Piperidines; Potassium; Pyrazoles; Quinolines; Renal Insufficiency, Chronic; Spironolactone | 2022 |
6 other study(ies) available for spironolactone and piperidines
| Article | Year |
|---|---|
[Anesthetic management for mediastinoscopy in a patient with severe pulmonary hypertension].
Topics: Anesthesia, General; Bundle-Branch Block; Dermatomyositis; Dyslipidemias; Epoprostenol; Female; Fentanyl; Furosemide; Humans; Hypertension; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Mediastinal Diseases; Mediastinoscopy; Methyl Ethers; Middle Aged; Oxygen Inhalation Therapy; Piperidines; Preoperative Care; Raynaud Disease; Remifentanil; Sevoflurane; Spironolactone | 2007 |
Activation of glucocorticoid receptors increases 5-HT2A receptor levels.
Topics: Analysis of Variance; Animals; Autoradiography; Corticosterone; Fluorobenzenes; Gene Expression Regulation; Hippocampus; Hormone Antagonists; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mifepristone; Mineralocorticoid Receptor Antagonists; Piperidines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Glucocorticoid; Serotonin Plasma Membrane Transport Proteins; Spironolactone; Tissue Culture Techniques; Tritium | 2009 |
The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats.
Topics: Animals; Carbamates; Cells, Cultured; Diphenhydramine; Drug Interactions; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Male; Microsomes, Liver; Organic Anion Transporters; Piperidines; Pravastatin; Rats; Rats, Sprague-Dawley; Spironolactone | 2013 |
Corticosteroid-endocannabinoid loop supports decrease of fear-conditioned response in rats.
Topics: Adrenal Cortex Hormones; Animals; Arachidonic Acids; Benzoxazines; Cannabinoid Receptor Modulators; Conditioning, Classical; Dexamethasone; Endocannabinoids; Extinction, Psychological; Fear; Freezing Reaction, Cataleptic; Male; Metyrapone; Mifepristone; Mineralocorticoid Receptor Antagonists; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Glucocorticoid; Rimonabant; Spironolactone | 2014 |
Glucocorticoid receptor antagonism disrupts the reconsolidation of social reward-related memories in rats.
Topics: Analysis of Variance; Animals; Cannabinoid Receptor Antagonists; Conditioning, Operant; Dizocilpine Maleate; Dose-Response Relationship, Drug; Hormone Antagonists; Male; Memory Disorders; Mifepristone; Mineralocorticoid Receptor Antagonists; Neuroprotective Agents; Piperidines; Pyrazoles; Rats; Rats, Wistar; Reward; Rimonabant; Social Behavior; Spironolactone | 2014 |
Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase.
Topics: 3T3-L1 Cells; Adipocytes, White; Aldosterone; Animals; Cell Line, Tumor; Dibenzocycloheptenes; Enzyme Induction; Humans; Insulin Resistance; Intra-Abdominal Fat; Intramolecular Oxidoreductases; Lipocalins; Male; Metabolic Syndrome; Mice; Mice, Obese; Mice, Transgenic; Mineralocorticoid Receptor Antagonists; Obesity; Piperidines; Receptors, Leptin; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Subcutaneous Fat; Up-Regulation | 2015 |